The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Immuno-Oncology Treatment-Global Market Insights and Sales Trends 2025
Synopsis
The global Immuno-Oncology Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Immuno-Oncology Treatment in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Center and Others,, are propelling Immuno-Oncology Treatment market. Immune Checkpoint Inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Monoclonal Antibodies segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immuno-Oncology Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immuno-Oncology Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immuno-Oncology Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immuno-Oncology Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immuno-Oncology Treatment covered in this report include Amgen, AstraZeneca, Bristol-Myers Squibb, Eli-Lilly, Roche, GlaxoSmithKline, Janssen Biotech, Merck and Novartis, etc.
The global Immuno-Oncology Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli-Lilly
Roche
GlaxoSmithKline
Janssen Biotech
Merck
Novartis
Pfizer
Sanofi
Spectrum Pharmaceuticals
Takeda
Global Immuno-Oncology Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immuno-Oncology Treatment market, Segment by Type:
Immune Checkpoint Inhibitors
Monoclonal Antibodies
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Global Immuno-Oncology Treatment market, by Application
Hospitals
Ambulatory Surgical Center
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Immuno-Oncology Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Immuno-Oncology Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Immuno-Oncology Treatment in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Center and Others,, are propelling Immuno-Oncology Treatment market. Immune Checkpoint Inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Monoclonal Antibodies segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immuno-Oncology Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immuno-Oncology Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immuno-Oncology Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immuno-Oncology Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immuno-Oncology Treatment covered in this report include Amgen, AstraZeneca, Bristol-Myers Squibb, Eli-Lilly, Roche, GlaxoSmithKline, Janssen Biotech, Merck and Novartis, etc.
The global Immuno-Oncology Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli-Lilly
Roche
GlaxoSmithKline
Janssen Biotech
Merck
Novartis
Pfizer
Sanofi
Spectrum Pharmaceuticals
Takeda
Global Immuno-Oncology Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immuno-Oncology Treatment market, Segment by Type:
Immune Checkpoint Inhibitors
Monoclonal Antibodies
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Global Immuno-Oncology Treatment market, by Application
Hospitals
Ambulatory Surgical Center
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Immuno-Oncology Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Immuno-Oncology Treatment
1.1 Immuno-Oncology Treatment Market Overview
1.1.1 Immuno-Oncology Treatment Product Scope
1.1.2 Immuno-Oncology Treatment Market Status and Outlook
1.2 Global Immuno-Oncology Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Immuno-Oncology Treatment Market Size by Region (2018-2029)
1.4 Global Immuno-Oncology Treatment Historic Market Size by Region (2018-2023)
1.5 Global Immuno-Oncology Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Immuno-Oncology Treatment Market Size (2018-2029)
1.6.1 North America Immuno-Oncology Treatment Market Size (2018-2029)
1.6.2 Europe Immuno-Oncology Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Immuno-Oncology Treatment Market Size (2018-2029)
1.6.4 Latin America Immuno-Oncology Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Immuno-Oncology Treatment Market Size (2018-2029)
2 Immuno-Oncology Treatment Market by Type
2.1 Introduction
2.1.1 Immune Checkpoint Inhibitors
2.1.2 Monoclonal Antibodies
2.1.3 Cytokine-Based Immunotherapy
2.1.4 Cancer Vaccines
2.1.5 CAR-T Cell Therapy
2.2 Global Immuno-Oncology Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Immuno-Oncology Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Immuno-Oncology Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Immuno-Oncology Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Immuno-Oncology Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Immuno-Oncology Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Immuno-Oncology Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Immuno-Oncology Treatment Revenue Breakdown by Type (2018-2029)
3 Immuno-Oncology Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Ambulatory Surgical Center
3.1.3 Others
3.2 Global Immuno-Oncology Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Immuno-Oncology Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Immuno-Oncology Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Immuno-Oncology Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Immuno-Oncology Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Immuno-Oncology Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Immuno-Oncology Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Immuno-Oncology Treatment Revenue Breakdown by Application (2018-2029)
4 Immuno-Oncology Treatment Competition Analysis by Players
4.1 Global Immuno-Oncology Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immuno-Oncology Treatment as of 2022)
4.3 Date of Key Players Enter into Immuno-Oncology Treatment Market
4.4 Global Top Players Immuno-Oncology Treatment Headquarters and Area Served
4.5 Key Players Immuno-Oncology Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Immuno-Oncology Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Amgen
5.1.1 Amgen Profile
5.1.2 Amgen Main Business
5.1.3 Amgen Immuno-Oncology Treatment Products, Services and Solutions
5.1.4 Amgen Immuno-Oncology Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Amgen Recent Developments
5.2 AstraZeneca
5.2.1 AstraZeneca Profile
5.2.2 AstraZeneca Main Business
5.2.3 AstraZeneca Immuno-Oncology Treatment Products, Services and Solutions
5.2.4 AstraZeneca Immuno-Oncology Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 AstraZeneca Recent Developments
5.3 Bristol-Myers Squibb
5.3.1 Bristol-Myers Squibb Profile
5.3.2 Bristol-Myers Squibb Main Business
5.3.3 Bristol-Myers Squibb Immuno-Oncology Treatment Products, Services and Solutions
5.3.4 Bristol-Myers Squibb Immuno-Oncology Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Eli-Lilly Recent Developments
5.4 Eli-Lilly
5.4.1 Eli-Lilly Profile
5.4.2 Eli-Lilly Main Business
5.4.3 Eli-Lilly Immuno-Oncology Treatment Products, Services and Solutions
5.4.4 Eli-Lilly Immuno-Oncology Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Eli-Lilly Recent Developments
5.5 Roche
5.5.1 Roche Profile
5.5.2 Roche Main Business
5.5.3 Roche Immuno-Oncology Treatment Products, Services and Solutions
5.5.4 Roche Immuno-Oncology Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Roche Recent Developments
5.6 GlaxoSmithKline
5.6.1 GlaxoSmithKline Profile
5.6.2 GlaxoSmithKline Main Business
5.6.3 GlaxoSmithKline Immuno-Oncology Treatment Products, Services and Solutions
5.6.4 GlaxoSmithKline Immuno-Oncology Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 GlaxoSmithKline Recent Developments
5.7 Janssen Biotech
5.7.1 Janssen Biotech Profile
5.7.2 Janssen Biotech Main Business
5.7.3 Janssen Biotech Immuno-Oncology Treatment Products, Services and Solutions
5.7.4 Janssen Biotech Immuno-Oncology Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Janssen Biotech Recent Developments
5.8 Merck
5.8.1 Merck Profile
5.8.2 Merck Main Business
5.8.3 Merck Immuno-Oncology Treatment Products, Services and Solutions
5.8.4 Merck Immuno-Oncology Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Merck Recent Developments
5.9 Novartis
5.9.1 Novartis Profile
5.9.2 Novartis Main Business
5.9.3 Novartis Immuno-Oncology Treatment Products, Services and Solutions
5.9.4 Novartis Immuno-Oncology Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Novartis Recent Developments
5.10 Pfizer
5.10.1 Pfizer Profile
5.10.2 Pfizer Main Business
5.10.3 Pfizer Immuno-Oncology Treatment Products, Services and Solutions
5.10.4 Pfizer Immuno-Oncology Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 Pfizer Recent Developments
5.11 Sanofi
5.11.1 Sanofi Profile
5.11.2 Sanofi Main Business
5.11.3 Sanofi Immuno-Oncology Treatment Products, Services and Solutions
5.11.4 Sanofi Immuno-Oncology Treatment Revenue (US$ Million) & (2018-2023)
5.11.5 Sanofi Recent Developments
5.12 Spectrum Pharmaceuticals
5.12.1 Spectrum Pharmaceuticals Profile
5.12.2 Spectrum Pharmaceuticals Main Business
5.12.3 Spectrum Pharmaceuticals Immuno-Oncology Treatment Products, Services and Solutions
5.12.4 Spectrum Pharmaceuticals Immuno-Oncology Treatment Revenue (US$ Million) & (2018-2023)
5.12.5 Spectrum Pharmaceuticals Recent Developments
5.13 Takeda
5.13.1 Takeda Profile
5.13.2 Takeda Main Business
5.13.3 Takeda Immuno-Oncology Treatment Products, Services and Solutions
5.13.4 Takeda Immuno-Oncology Treatment Revenue (US$ Million) & (2018-2023)
5.13.5 Takeda Recent Developments
6 North America
6.1 North America Immuno-Oncology Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Immuno-Oncology Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Immuno-Oncology Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Immuno-Oncology Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Immuno-Oncology Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Immuno-Oncology Treatment Market Dynamics
11.1 Immuno-Oncology Treatment Industry Trends
11.2 Immuno-Oncology Treatment Market Drivers
11.3 Immuno-Oncology Treatment Market Challenges
11.4 Immuno-Oncology Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
